At #TRICON2025, our CEO, Mark Bagnall, will present as a part of TRI-CON’s new track on precision medicine beyond oncology. We’re thrilled to be part of the new track exploring precision medicine applications in metabolic diseases, neurology, and immunology. Join us in San Diego to learn more about how MyPhenome Test is transforming treatment strategies and improving patient outcomes. Use speaker code SPK300?to receive a $300 discount when registering at https://lnkd.in/eC3e8tp
Phenomix Sciences
生物技术研究
St Paul，Minnesota 2,007 位关注者
Combating obesity with data-driven precision medicine.
关于我们
Phenomix Sciences is a precision medicine obesity biotechnology pioneer on a mission to conquer obesity globally through the science of phenotyping, the understanding of how genes combined with environmental and behavioral factors can inform obesity treatment plans. Mayo Clinic physicians, scientists, and researchers, Drs. Acosta and Camilleri, founded the company under the belief that the key to understanding obesity is unprecedented access to its clinical and molecular information throughout all stages and phenotypes of the disease. Phenomix leverages data intelligence to yield better accuracy in predicting individual patient response to specific weight loss interventions and reducing the variability in weight loss results for patients.
- 网站
-
https://www.phenomixsciences.com
Phenomix Sciences的外部链接
- 所属行业
- 生物技术研究
- 规模
- 2-10 人
- 总部
- St Paul，Minnesota
- 类型
- 私人持股
- 创立
- 2021
- 领域
- Biotech、Lifescience、Metabolomics、Genomics、Obesity、Diagnostics、Personalized Medicine、Data Intelligence、AI、Machine Learning、Obesity Biobank、Weight Loss和DNA
地点
-
主要
获取路线
1000 Westgate Dr
1003
US，Minnesota，St Paul，55114
Phenomix Sciences员工
动态
-
"The most important tool for serving patients taking GLP-1s is to know what they’re going through and be able to guide them along the way." Check out our co-founder Andres Acosta M.D., Ph.D. in Medscape where he shares his thoughts on the latest research around GLP-1s and how treating obesity can be key in overall health beyond just weight loss. https://lnkd.in/gaJFq3m7
-
Andres Acosta M.D., Ph.D., Mark Bagnall, and Liv Williamsen (Founder, CEO, and COO of Phenomix Sciences) came together at the Precision Medicine World Conference this week alongside our new partners at InformedDNA, the country’s leading applied genomics solutions company. Our partnership emphasizes empowering patients and providers with personalized health solutions tailored to each individual to drive better outcomes. We are excited to continue expanding our work with stakeholders like InformedDNA and others across the spectrum who share our desire to ensure the right therapeutics reach the right patients. #PrecisionMedicine #ObesityCare #MyPhenomeTest #InformedDNA #HealthcareInnovation #PMWC Special shout out to Erin Engel, for capturing our fabulous team photo!
-
-
Andres Acosta M.D., Ph.D. took the stage today at #PMWC2025 to showcase how metabolic subtypes are driving a paradigm shift in obesity care. His talk, "Machine-learning Assisted Gene Risk Score Predicts Response to GLP-1s," revealed groundbreaking insights into why responses to GLP-1s and other metabolic interventions vary—and how we can now predict outcomes with precision. ? Powered by advanced machine learning, the MyPhenome Test is the first-of-its-kind diagnostic tool to personalize obesity treatments. This is the future of healthcare, optimizing outcomes and improving lives. ? #PrecisionMedicine #ObesityCare #MyPhenomeTest #HealthcareInnovation #GLP1 #AIClinicalApplication
-
-
Phenomix Sciences hosts its first HCP dinner, Art of Precision Obesity Medicine in Oak Brook, Il. Incredible and lively evening with an excellent presentation by Zaid Jabbar, MD MS ABIM ABOM. Many thanks to all those who attended and provided an engaging and thoughtful evening. #precisionobesitymedicine #metabolicsubtyes #obesityphenotyping
-
-
Join Dr. Melina and Dr. Andres Acosta on the Practically Healthy podcast as they sit down for a deep dive into the science of precision obesity medicine. In this episode, Dr. Acosta shares how DNA can guide weight loss strategies, making health more personal and powerful! Don’t miss this inspiring conversation about the future of personalized medicine and nutrition approaches using MyPhenome Test! ???? #practicallyhealthy #obesitymedicine #precisionnutrition #personalizedmedicine https://lnkd.in/g4z56d-y
Precision Medicine for Weight Loss: Dr. Andres Acosta | Practically Healthy by Dr. Melina
practicallyhealthybydrmelina.podbean.com
-
Join Dr. Melina and Dr. Andres Acosta on the Practically Healthy podcast as they sit down for a deep dive into the science of precision obesity medicine. In this episode, Dr. Acosta shares how DNA can guide weight loss strategies, making health more personal and powerful! Don’t miss this inspiring conversation about the future of personalized medicine and nutrition approaches using MyPhenome Test! ???? #practicallyhealthy #obesitymedicine #precisionnutrition #personalizedmedicine https://lnkd.in/g4z56d-y
Precision Medicine for Weight Loss: Dr. Andres Acosta | Practically Healthy by Dr. Melina
practicallyhealthybydrmelina.podbean.com
-
Phenomix Sciences is excited to collaborate with InformedDNA to deliver #MyPhenome test as part of their metabolic package they provide to patients.
I am excited to announce our new partnership with Phenomix. I'll be at HLTH next week if you want to learn more. https://lnkd.in/gf5qdE-A
-
We’re honored to announce our partnership with Novo Nordisk's Transformational Prevention Unit to find science-based solutions to obesity using the MyPhenome test. Together, we’re diving deep into the complexities of obesity to transform how we predict, prevent and treat this global health issue. This collaboration represents a pivotal moment in our journey to help healthcare providers deliver personalized, effective obesity care. We’re proud to be working alongside such a forward-thinking partner and excited to see the impact this will have on the future of obesity precision medicine. #Obesity #PrecisionMedicine #PhenomixSciences #MyPhenome
Partnerships. That’s one of our core pillars in the Novo Nordisk Transformational Prevention Unit (TPU), where we explore science-based solutions to prevent obesity. ? Today, I am happy to share that the TPU Novo Nordisk has kicked-off a research partnership with Phenomix Sciences, a biotech company. ? Through an in-depth study of people living with obesity, Phenomix Sciences have proposed a precision medicine approach to obesity. How does this approach work? It uses newly identified sub-groups of obesity to find the underlying causes and link this to a more tailored way to tackle the disease. In our research collaboration, we will explore whether we can apply such a precision medicine approach to obesity prevention and predict the predisposition to specific sub-groups of obesity. ? This partnership is just the start of our journey, and while there are still many unknowns to address before we achieve a solution, it represents a step forward in our mission to help halt the global rise of obesity. We will continue to look for and build innovative partnerships to drive change to defeat serious chronic diseases like obesity. #PrecisionMedicine #Prevention #Innovation #Partnerships
-
We’re honored to announce our partnership with Novo Nordisk's Transformational Prevention Unit to find science-based solutions to obesity using the MyPhenome test. Together, we’re diving deep into the complexities of obesity to transform how we predict, prevent and treat this global health issue. This collaboration represents a pivotal moment in our journey to help healthcare providers deliver personalized, effective obesity care. We’re proud to be working alongside such a forward-thinking partner and excited to see the impact this will have on the future of obesity precision medicine. #Obesity #PrecisionMedicine #PhenomixSciences #MyPhenome
Partnerships. That’s one of our core pillars in the Novo Nordisk Transformational Prevention Unit (TPU), where we explore science-based solutions to prevent obesity. ? Today, I am happy to share that the TPU Novo Nordisk has kicked-off a research partnership with Phenomix Sciences, a biotech company. ? Through an in-depth study of people living with obesity, Phenomix Sciences have proposed a precision medicine approach to obesity. How does this approach work? It uses newly identified sub-groups of obesity to find the underlying causes and link this to a more tailored way to tackle the disease. In our research collaboration, we will explore whether we can apply such a precision medicine approach to obesity prevention and predict the predisposition to specific sub-groups of obesity. ? This partnership is just the start of our journey, and while there are still many unknowns to address before we achieve a solution, it represents a step forward in our mission to help halt the global rise of obesity. We will continue to look for and build innovative partnerships to drive change to defeat serious chronic diseases like obesity. #PrecisionMedicine #Prevention #Innovation #Partnerships